TRD3: Percutaneous and Interstitial Imaging

TRD3:经皮和间质成像

基本信息

  • 批准号:
    9275998
  • 负责人:
  • 金额:
    $ 35.69万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

Project Summary TRD 3 The overall goal of TRD 3 is to enable advanced OCT imaging, with high resolution and functional and dynamic contrast, inside the living body, through narrow diameter, rotational probes. Instruments and algorithms will be developed that overcome fundamental barriers, intrinsic to flexible, rotational fiber-optic probes, that have previously compromised image quality and prohibited the integration of functional and dynamic contrast. Specific Aim 1 addresses the need for functional imaging of blood flow in the coronary arteries. In catheter- based OCT a side-looking fiber-optic probe performs a helical scan pattern and records the reflectivity profile as a function of depth at each scan location. For normal imaging of the arteries, the blood is displaced by injecting a clear contrast agent. Recording, instead, time sequences without injection produces a rapidly fluctuating signal related to the blood flow. Based on accurate modeling of this signal, a reconstruction algorithm to extract vectorial blood flow profiles will be developed. Eliciting the overall flow rate offers a key parameter for the assessment of atherosclerotic lesions in human coronary arteries. Flow is also a critical factor in endothelial dysfunction and atherogenesis. The ability to map turbulence and detailed flow profiles offers a new avenue for the study of preclinical mouse models of atherosclerosis. Specific Aim 2 explores the polarization properties of biological tissue. Polarization sensitive detection measures the polarization state of the backscattered light. Combined with two orthogonal polarization states for illumination, this provides a complete characterization of the polarization properties of the tissue. However, the spinning catheter and the superimposed tissue impact and bias the polarization states at each depth. A reconstruction strategy to extract the depth-resolved polarization properties, including birefringence, optic axis and depolarization will be developed. Polarization contrast will help in differentiating between acute and chronic thrombus, which is an unresolved challenge in the clinical management of deep vein thrombosis, and in identifying different plaque types in atherosclerosis. Specific Aim 3 responds to the need for catheter-based imaging in preclinical small animal research. Narrow diameter rotational OCT probes, small enough to access the vascular system in small animals, or image interstitial tissue accessed through the bore of a hypodermic needle will be developed. The miniature probes will compensate the astigmatism originating from the transparent narrow diameter sheath that is protecting the spinning probe, and achieve a high quality and tight focus. Combined with a stable scanning mechanism this will enable high resolution imaging of the minute anatomy in the organs of small animals. Combined, these efforts will improve the diagnostic capability of OCT by providing additional contrast and functional parameters and expand the application of OCT to tissues and organs previously out of its reach.
项目摘要 TRD 3 TRD 3的总体目标是实现先进的OCT成像,具有高分辨率和功能, 动态对比,在活体内,通过窄直径,旋转探头。文书和 将开发克服柔性旋转光纤固有的基本障碍的算法 探头,以前已经损害了图像质量,并禁止功能和 动态对比 特定目标1解决了冠状动脉中血流功能成像的需求。在导管中- 基于OCT,侧视光纤探头执行螺旋扫描模式并记录反射率轮廓 作为每个扫描位置处的深度的函数。对于动脉的正常成像,血液被 注射透明的造影剂相反,记录时间序列而不注射产生快速的 与血流有关的波动信号。基于对该信号的精确建模, 将开发用于提取矢量血流轮廓的算法。得出总流速提供了一个关键 用于评估人冠状动脉中动脉粥样硬化病变的参数。流动也是一个关键 内皮功能障碍和动脉粥样硬化形成的因素。能够绘制湍流和详细的流动剖面图 为动脉粥样硬化的临床前小鼠模型的研究提供了新的途径。 具体目标2探索生物组织的偏振特性。偏振灵敏检测 测量后向散射光的偏振状态。结合两个正交偏振态, 通过使用照明,这提供了组织的偏振特性的完整表征。但 旋转的导管和叠加的组织影响并偏置每个深度处的偏振状态。一 重建策略,以提取深度分辨偏振特性,包括双折射,光轴 并且将产生去极化。偏振对比度将有助于区分急性和 慢性血栓,这是深静脉血栓临床管理中尚未解决的挑战,以及 在识别动脉粥样硬化中不同类型的斑块方面。 Specific Aim 3响应了临床前小动物研究中对基于导管的成像的需求。窄 直径旋转OCT探头,小到足以进入小动物的血管系统,或成像 通过皮下注射针的孔进入的间质组织将发育。微型探测器 将补偿源自保护所述透镜的透明窄直径护套的像散, 旋转探头,实现高质量和紧密聚焦。结合稳定的扫描机制, 将使小动物器官中微小解剖结构的高分辨率成像成为可能。 结合起来,这些努力将通过提供额外的对比度来提高OCT的诊断能力, 功能参数,并将OCT的应用扩展到以前无法达到的组织和器官。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Martin Villiger其他文献

Martin Villiger的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Martin Villiger', 18)}}的其他基金

Universal optical coherence polarimetry
通用光学相干偏振测定法
  • 批准号:
    10661749
  • 财政年份:
    2022
  • 资助金额:
    $ 35.69万
  • 项目类别:
Quantitative imaging of collagen morphology in human scars
人类疤痕中胶原形态的定量成像
  • 批准号:
    9544197
  • 财政年份:
    2017
  • 资助金额:
    $ 35.69万
  • 项目类别:
TRD3: Endoscopic and Probe-based Coherence Imaging
TRD3:内窥镜和基于探头的相干成像
  • 批准号:
    10650844
  • 财政年份:
    2011
  • 资助金额:
    $ 35.69万
  • 项目类别:
TRD3: Endoscopic and Probe-based Coherence Imaging
TRD3:内窥镜和基于探头的相干成像
  • 批准号:
    10494623
  • 财政年份:
    2011
  • 资助金额:
    $ 35.69万
  • 项目类别:
TRD3: Percutaneous and Interstitial Imaging
TRD3:经皮和间质成像
  • 批准号:
    9977191
  • 财政年份:
  • 资助金额:
    $ 35.69万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.69万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.69万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 35.69万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.69万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.69万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.69万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.69万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 35.69万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 35.69万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 35.69万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了